Mortgage loans rebounds at unremarkable 9.8%

It shows slow property transactions.

According to Barclays, while the February mortgage survey showed new mortgage loans drawn down slightly rebounded to HK$11.4bn, +9.8% m/m (vs -6.2% m/m in January), the amount was still at low level, showing a continuation of slow property transactions and weaker sentiment.

However, outstanding mortgages only inched up by 0.5% m/m, as new mortgage loans booked offset principal repayments.

Here’s more from Barclays:

The proportion of Prime-based mortgages that are priced below 2.25% (effective rate) reduced to 36.7% in February (vs. 48% in January), reflecting easing pricing competition.

Hibor-based mortgages rose to 54.8% up from 41.7% in January.

Overall, we estimate that the average system mortgage rate was stable at 2.18% and is unlikely to fall substantially lower due to the 15% mortgage risk weight floor limit imposed by the HKMA since February 2013.
 

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Hong Kong and Shanghai to enhance financial ties
The two cities will leverage on their competitive advantage to boost their financial cooperation.
HK Express load factors exceed 97% in April amidst Easter holidays
Current bookings to North Asian destinations exceed 90% occupancy as Golden Week approaches.
Aviation
PolyU partners with ZEISS for myopia control tech advancement
The partnership focuses on developing myopia control and other ophthalmic technologies.
Healthcare